The breadth of data reinforces the company's expertise across dermatology and immunology, and reflects the ongoing commitment to safe, effective medications ...
The Korsch X3 is a state-of-the-art tablet press, custom-built to fit the site's needs. The press is equipped with full Band ...
Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control blood sugar levels in ...
March 27, 2026 - PRESSADVANTAGE - Cardinal Compliance Consultants, LLC has announced its participation in the Ohio ...
4d
Merck buying Terns in $6.7B deal to bolster its cancer portfolio before key Keytruda patent expires
Merck is buying oncology company Terns Pharmaceuticals in a deal valued at approximately $6.7 billion as the pharmaceutical ...
Medtronic said on Friday the U. Food and Drug Administration has cleared its surgical system for use in cranial and ...
AI-generated videos impersonating medical professionals are claiming specialists are facing pushback for revealing foods that ...
Oral peptide specialist Pinnacle Medicines has secured an $89 million series B with backing from investors in the U.S. and ...
Apnimed, Inc., a pharmaceutical company developing an oral drug product candidate, AD109, that is designed to address a root cause of obstructive sleep apnea (OSA), today announced that Shionogi & Co.
The naming-rights deal was unveiled by Riverview Health, Parkview Health of Fort Wayne and city officials at a press ...
Independent skincare brands across the United States are facing a market that rewards differentiation at every level — and ...
Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results